Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 6 August 2009, Vol. 114, No. 6, pp. 1254-1262.
Prepublished online as a Blood First Edition Paper on June 15, 2009; DOI 10.1182/blood-2009-03-210146.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Methods, Table, and Figures
Right arrow All Versions of this Article:
blood-2009-03-210146v1
114/6/1254    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Wahlberg, K.
Right arrow Articles by Best, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wahlberg, K.
Right arrow Articles by Best, S.
Related Collections
Right arrow Red Cells, Iron, and Erythropoiesis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

RED CELLS, IRON, AND ERYTHROPOIESIS

The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells

Karin Wahlberg1, Jie Jiang1, Helen Rooks1, Kiran Jawaid1, Fumihiko Matsuda2,3, Masao Yamaguchi2,3, Mark Lathrop3, Swee Lay Thein1,4,*, and Steve Best1,*

1 Division of Gene and Cell Based Therapy, King's College London School of Medicine, London, United Kingdom; 2 Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Yoshida, Japan; 3 Centre National de Génotypage, Institut Génomique, Commissariat a l'Energie Atomique, Evry, France; and 4 Department of Haematological Medicine, King's College Hospital, London, United Kingdom

HBS1L-MYB intergenic polymorphism (HMIP) on chromosome 6q23 is associated with elevated fetal hemoglobin levels and has pleiotropic effects on several hematologic parameters. To investigate potential regulatory activity in the region, we have measured sensitivity of the sequences to DNase I cleavage that identified 3 tissue-specific DNase I hypersensitive sites in the core intergenic interval. Chromatin immunoprecipitation with microarray (ChIP-chip) analysis showed strong histone acetylation in a defined interval of 65 kb corresponding to the core HBS1L-MYB intergenic region in primary human erythroid cells but not in non–MYB-expressing HeLa cells. ChIP-chip analysis also identified several potential cis-regulatory elements as strong GATA-1 signals that coincided with the DNase I hypersensitive sites present in MYB-expressing erythroid cells. We suggest that HMIP contains regulatory sequences that could be important in hematopoiesis by controlling MYB expression. This study provides the functional link between genetic association of HMIP with control of fetal hemoglobin and other hematologic parameters. We also present a large-scale analysis of histone acetylation as well as RNA polymerase II and GATA-1 interactions on chromosome 6q, and {alpha} and β globin gene loci. The data suggest that GATA-1 regulates numerous genes of various functions on chromosome 6q.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. L. Thein, S. Menzel, M. Lathrop, and C. Garner
Control of fetal hemoglobin: new insights emerging from genomics and clinical implications
Hum. Mol. Genet., October 15, 2009; 18(R2): R216 - R223.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020